Stockreport

Edesa Biotech Reports Fiscal 2nd Quarter 2024 Results [Yahoo! Finance]

Edesa Biotech, Inc. - Common Shares  (EDSA) 
PDF host-directed therapeutics for immuno-inflammatory diseases, today reported financial results for the three and six months ended March 31, 2024 and provided an update on [Read more]